Symyx Joins Pistoia Alliance to Streamline Drug Discovery Workflows
31 Mars 2010 - 2:00PM
Symyx Technologies, Inc. (Nasdaq:SMMX) today announced it has
joined the Pistoia Alliance, a non-profit group that promotes
collaboration to streamline non-competitive elements of
pharmaceutical and life science discovery workflows. The alliance
was initially formed by major global pharmaceutical companies
including Pfizer, GlaxoSmithKline, Novartis, and AstraZeneca.
"By enrolling in the Pistoia Alliance, we are taking an active
and cooperative position with our customers in their efforts to
optimize the drug discovery process," said Dr. Trevor Heritage,
president of Symyx's software business unit. "Additionally, through
the open-source nature of Pistoia, Symyx's valuable experience
working in a variety of markets with thousands of customers on
these types of research workflow challenges will be available to
other alliance members."
Symyx is participating in the Electronic Lab Notebook (ELN)
Query Services Working Group that over time will create and release
industry standard definitions, a Search application programming
interface (API), and a service specification for accessing and
reporting ELN information. These cooperative efforts will provide
for the current and future digital information needs of Symyx
customers, while also helping to establish a set of standard
industry use cases that will align life sciences customers and
vendors around the challenges of working with information
throughout the discovery process.
As a participating member of the Pistoia Alliance, Symyx will
collaborate on helping companies increase the value of research
information by enabling searching and reporting across the groups,
domains, and systems involved in research projects. In today's
cost-driven R&D environment, companies realize that working
together to capture and discuss emerging ideas can be mutually
beneficial.
For more information about Symyx software and scientific
databases, visit www.symyx.com or contact
inforequest@symyx.com.
About Symyx
Symyx Technologies, Inc. (Nasdaq:SMMX) helps R&D-based
companies in life sciences, chemicals, energy, and consumer and
industrial products achieve breakthroughs in innovation,
productivity, and return on investment. Symyx software and
scientific databases power laboratories with the information that
generates insight, enhances collaboration, and drives productivity.
Products include a market-leading electronic laboratory notebook,
decision support software, and chemical informatics and sourcing
databases. Information about Symyx, including reports and other
information filed by Symyx with the Securities and Exchange
Commission, is available at www.symyx.com.
The Symyx Technologies, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=6120
CONTACT: The Racepoint Group on behalf of
Symyx Technologies, Inc.
Raymond Deplazes
(415) 694-6715
rdeplazes@racepointgroup.com
Symyx Technologies (MM) (NASDAQ:SMMX)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Symyx Technologies (MM) (NASDAQ:SMMX)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024